Global /China /Healthcare /Medical Distribution /301166

Shanghai Universal Biotech Co.,Ltd.

301166

• SHE: 301166 • Delayed

30.88CNY 1.7%

4.56 USD

As of 5 June 2026, Shanghai Universal Biotech Co.,Ltd. has a market cap of $391.24M USD, ranking #16831 globally and #5260 in China. It ranks #1526 in the Healthcare sector, and #50 in the Medical Distribution industry.

Global Rank

16831

Country Rank

5260

Sector Rank

1526

Industry Rank

Key Stats

Market Cap

$391.24MUSD

2.65B CNY

Enterprise Value

$224.36MUSD

1.52B CNY

Revenue (TTM)

$157.54MUSD

1.07B CNY

EBITDA (TTM)

-$5.95MUSD

-40.25M CNY

Net Income (TTM)

-$2.81MUSD

-19.01M CNY

EBITDA Margin

-3.8%

Profit Margin

-1.8%

PS Ratio

2.5

PB Ratio

1.3

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Medical Distribution

CEO

Zhaowu Leng open_in_new

Employees

698

Founded

2004

Website

univ-bio.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
1.7%	-0.9%	0.2%	-6.8%	-4.2%	2.3%	8.9%	-36%	-71%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	301166 上海优宁维生物科技股份有限公司 Class A ISIN: CNE100005709 Shares Out.: Shares Outstanding: 84.849M¹ Shares Float: 53.501M² TV: TradingView: SZSE: 301166 SA: Stock Analysis: SHE: 301166 YF: Yahoo Finance: 301166.SZ GF: Google Finance: SHE: 301166 BA: Barron's: 301166 MS: Morningstar: XSHE: 301166	30.88 CNY	TV: TradingView: SZSE: 301166 SA: Stock Analysis: SHE: 301166 YF: Yahoo Finance: 301166.SZ GF: Google Finance: SHE: 301166 BA: Barron's: 301166 MS: Morningstar: XSHE: 301166

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Shanghai Universal Biotech Co.,Ltd.

Shanghai Universal Biotech Co.,Ltd. distributes and supplies antibodies and protein products. The company offers antibodies, recombinant proteins, detection kits, antigens, and other products, as well as immunology reagents, molecular biology reagents, cell biology reagents and biochemical reagents. It also provides technical services, technology promotion, technology information exchange, scientific and technology training, technology consulting, technology incubation and other services, as well as experimental services and software solutions. The company also sells products online. It serves colleges and universities, research institutes, hospitals, and biomedical companies. The company was founded in 2004 and is based in Shanghai, China.

Similar Companies

Industry: Medical Distribution (China)

Name	Market Cap (USD) diff.	PE	Country
Sinopharm Group Co. Ltd. SHEK: 1099	$7.48B 58.61B HKD 2K%	7.2	China
Jointown Pharmaceutical Group Co., Ltd. SSE: 600998	$3.82B 25.88B CNY 877%	13.3	China
Shanghai C&D INNOSTIC Medical Technology Group Co., Ltd. SHE: 301584	$1.63B 11.06B CNY 318%	31.2	China
Shenzhen Neptunus Bioengineering Co., Ltd. SHE: 000078	$1.24B 8.37B CNY 216%	-	China
Shinva Medical Instrument Co.,Ltd. SSE: 600587	$1.23B 8.31B CNY 214%	17.9	China
Shanghai Haohai Biological Technology Co., Ltd. SSE: 688366	$1.22B 8.24B CNY 211%	35.2	China

Industry: Medical Distribution (Global)

Name	Market Cap (USD) diff.	PE	Country
McKesson Corp. NYSE: MCK	$100.76B 26K%	24.0	United States
Cencora, Inc. NYSE: COR	$60.58B 15K%	37.4	United States
Cardinal Health, Inc. NYSE: CAH	$47.73B 12K%	29.6	United States
Henry Schein, Inc. NASDAQ: HSIC	$8.47B 2K%	22.6	United States
Galenica AG SIX: GALE	$5.3B 4.2B CHF 1K%	23.0	Switzerland
DKSH Holding AG SIX: DKSH	$4.83B 3.83B CHF 1K%	18.9	Switzerland

chevron_leftBack